샘 알트만이 메트포민을 복용하는 이유
GeoGazet 인텔리전스· 2026년 10월 5일 업데이트됨· 1분 읽기· 482 조회수
There is no credible evidence that Sam Altman, OpenAI's CEO since 2019, takes metformin.
This claim lacks substantiation in public records, health disclosures, or verified reporting.
Altman's health information remains private.
전체 보고서 읽기줄여서 보기
샘 알트만이 메트포민을 복용하는 이유
Public Focus on AI Development
Altman's documented activities center on OpenAI's product roadmap. Recent initiatives include OpenAI Dots, his unveiled ChatGPT AI personal agent, alongside the 2026 DevDay announcements. His tracked signals show 94 connections to Artificial Intelligence developments.
Speculation Without Basis
Health rumors about prominent figures often circulate online without verification. Without direct statements from Altman or credible medical sources, claims about his medications should be treated as unsubstantiated speculation rather than fact.
알트먼을 실시간으로 팔로우하세요.모든 업데이트는 우리의 텔레그램에 게시됩니다.
텔레그램 가입독자 리뷰
아직 리뷰가 없습니다. 첫 번째로 의견을 공유하세요.